Leonard J. Seigel, MD, FACP

Leonard J. Seigel, MD, FACP photo
(954) 267-7799
Hematology and Oncology
Holy Cross Medical Group: 

Office Hours
Monday-Friday | 9:00am to 12:00pm, 1:00pm to 4:00pm

Focus Area

American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Medical Oncology

Internship / Residency / Fellowship
Fellowship, Oncology - National Cancer Institute - Bethesda, MD (1985)
Fellowship, Hematology - Mount Sinai Hospital - New York, NY (1980)
Residency, Internal Medicine - Mount Sinai Hospital - New York, NY (1978)
Internship, Internal Medicine - Mount Sinai Hospital - New York, NY (1976)

Higher Education
George Washington University School of Medicine, M.D. - Washington, D.C. (1975)

Hollinshead, A., Tarro,G., Foster, W.A., Seigel, L.J., and Jaffurs W.: Studies of Tumor Specific and Herpes Virus Non-Virion Antigens. Cancer Research, 34: 1122-1125, 1964.

Seigel, L.J., and Longo, D.L.: he Control of Chemotherapy induced Emesis. Annals of Internal Med, 95:352-359,1981.

Seigel, L.J., Harper, M.E., Wong-Staal, F., Gallo, R.C., Nash, W.G. and O’Brien, S.J., Gene for t- cell Growth Factor: Location on Human Chromosome 4q and Feline Chromosome B1. Science, 223:175-178, 1984.

Seigel, L.J., Harper, M.E., Wong-Staal, F., Gallo, R.C., Nash, W.G., and O’Brien, S.J., A Genetic Analysis of HTLV Integration in HUT 102 and the localization of the Structural Gene for T-Cell Growth Factor to Chromosome 4. Gallo, R.C. and Essex (Eds): Cancer Cells Cold Spring Harbor Conference on Human T-Cell Leukemia Viruses. New York, Cold Spring Harbor Publ. 1985.

O’Brien, S.J., Nash, W.G., Bauer, R., Chang, E.H., and Seigel, L.J.: Trends in Chromosomal and Oncogene Evolution in Vertebrates. In Vitro. 204-214, 1985.

Seigel, L.J., Ratner, L., Joseph, S.F., Dense, D., Feinberg, M.B., Reyes, G.R. O’Brien, S.J., and Wong –Staal, F., Transactivation Induced by Human T-Lymphotropic Virus Type III Maps to a Viral Sequence Encoding 58 Amino Acids and Lacks Tissue Specificity. Virology. 148, 226-231, 1986.

Seigel, L.J., Nash, W.G., Poiesz, B.J., Moore, J.L., and O’Brien, S.J.: Dynamic and Non-Specific Dispersal of Human T-Cell Leukemia/Lymphoma Virus Type-1 Integration in Cultured Lymphoma Cells. Virology. 154, 67-75.1986.

Josephs, S.F., Reza-Sadaic, M., Heisig, V., Seigel, L.J., Franza, B.R., Renan, M.J. and Wong-Staal, F.: Synergism of Enhancer and Spl Binding Site elements in HTLV-III TRDirected
Gene Expression. Cell. 1986

Lilenbaum, R., Cano, R. Schwartz, M., Seigel, L.J., Lutzky, J., Lewis, M., Krill, E., Barreras, L. Davila, E.: Gemcitabine and Vinorelbine in Advanced Non-small Cell Lung Carcinoma. Cancer. 88, 557-62, 2000.

Lilenbaum, R., Schwartz, M., Seigel, L.J., Belette, F., Blaustein, A., Wittlin, F.N. Davila, E.: Phase II Trial of Weekly Docetaxel in Second Line Therapy for Non-small Cell Lung Carcinoma. Cancer. 92,2158-63,2001.

Lilenbaum, R., Rubin, M., Samuel, J., Boros, L., Chidiac, T., Seigel, L.J., Dowlati, A., Graham, P., Beaumont, J., Du, H.: A Randomized Phase II Trial of Two schedules of Docetaxel in Elderly or Poor Performance Status Patients with Advanced Non-small Cell Lung Cancer. J. Thorac Oncol. 2, 306-311, 2007.

Lilenbaum, R., Raez, L., Tseng, J., Seigel, L.J., Davila, E.: Efficacy and Safety of Oxaliplatin and Gemcitabine with Bevacizumab in Advanced Nonsmall Cell Lung Cancer. Interntl Assn Study of Lung Cancer. 3 (5): 511-15, 2008.


4725 N. Federal Highway, Cancer Center
33308 Fort Lauderdale , FL

HCMG Practice Locations